Brief: Initiator Pharma Receives Grant From Innovation Fund Denmark
Nov 5 (Reuters) - Initiator Pharma A/S INIT.TE :
* INITIATOR PHARMA RECEIVES GRANT FROM INNOVATION FUND
DENMARK
* INITIATOR PHARMA A/S - RECEIVED A COMMITMENT FROM
INNOVATION
FUND DENMARK TO SUPPORT CLINICAL DEVELOPMENT OF IP2018
* INITIATOR PHARMA A/S - INNOBOOSTER GRANT WILL FUND ONGOING
IP2018 PHASE 2A CLINICAL TRIAL WITH UP TO 3.8 MDKK.
Source text for Eikon: ID:nWkr2v0SCm
Further company coverage: INIT.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD